EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

S Van Assen, N Agmon-Levin, O Elkayam… - Annals of the …, 2011 - ard.bmj.com
Objectives To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for vaccination in patients with autoimmune inflammatory rheumatic …

Recommendations for the management of autoinflammatory diseases

NM Ter Haar, M Oswald, J Jeyaratnam… - Annals of the …, 2015 - ard.bmj.com
<p>Autoinflammatory diseases are characterised by fever and systemic inflammation, with
potentially serious complications. Owing to the rarity of these diseases, evidence-based …

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

MW Heijstek, LMO De Bruin, M Bijl, R Borrow… - Annals of the …, 2011 - ard.bmj.com
Evidence-based recommendations for vaccination of paediatric patients with rheumatic
diseases (PaedRD) were developed by following the EULAR standardised procedures for …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, MW Heijstek… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for vaccination
in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published …

Myeloid‐related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease …

M Frosch, A Strey, T Vogl, NM Wulffraat… - … : Official Journal of …, 2000 - Wiley Online Library
Objective To analyze which physiologic stimuli induce secretion of myeloid‐related protein
8 (MRP8) and MRP14, two S100 proteins expressed in neutrophils and monocytes, and to …

Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

AR Gennery, MA Slatter, L Grandin, P Taupin… - Journal of allergy and …, 2010 - Elsevier
BACKGROUND: Hematopoietic stem cell transplantation remains the only treatment for
most patients with severe combined immunodeficiencies (SCIDs) or other primary …

Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus

A Martini, A Ravelli, T Avcin, MW Beresford… - The Journal of …, 2019 - jrheum.org
Objective. To revise the current juvenile idiopathic arthritis (JIA) International League of
Associations for Rheumatology (ILAR) classification criteria with an evidence-based approach, …

Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study

W de Jager, EPAH Hoppenreijs, NM Wulffraat… - Annals of the …, 2007 - ard.bmj.com
Background: Juvenile idiopathic arthritis (JIA) consists of a heterogeneous group of disorders
with, for the most part, an unknown immunopathogenesis. Although onset and disease …

Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study

M Aldenhoven, RF Wynn, PJ Orchard… - Blood, The Journal …, 2015 - ashpublications.org
Mucopolysaccharidosis type I–Hurler syndrome (MPS-IH) is a lysosomal storage disease
characterized by multisystem morbidity and death in early childhood. Although hematopoietic …

Treating juvenile idiopathic arthritis to target: recommendations of an international task force

A Ravelli, A Consolaro, G Horneff, RM Laxer… - Annals of the …, 2018 - ard.bmj.com
Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The …